Stay updated on Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision badge updated from v3.6.4 to v3.6.5, indicating a minor platform release. The update does not alter study details or visible content on the page.
    Difference
    0.0%
    Check dated 2026-08-10T13:01:17.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 tag was added and several unrelated topics/links along with an older Revision tag were removed, indicating a metadata cleanup rather than changes to the trial data.
    Difference
    0.2%
    Check dated 2026-07-27T06:19:31.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added related topics: Lung cancer, related topics, and MedlinePlus Genetics to the study record, improving contextual linkage to related resources. The change enhances navigation and discoverability without altering the study's content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-12T20:21:51.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.3' was added to the site's revision log, while older items including 'Lung cancer', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.6.2' were removed.
    Difference
    0.2%
    Check dated 2026-07-05T13:27:26.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added Lung cancer and related topics with a MedlinePlus Genetics link to the page's information section. The revision tag was updated to v3.6.2, replacing the previous v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-28T08:16:28.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page's MedlinePlus related topics section has had items removed, including Lung cancer and MedlinePlus Genetics, along with the related topics header.
    Difference
    0.1%
    Check dated 2026-06-21T00:23:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.